ImportRefusal LogoImportRefusal

Hikma Pharmaceuticals USA, Inc.

⚠️ Moderate Risk

FEI: 2250102 • Eatontown, NJ • UNITED STATES

FEI

FEI Number

2250102

📍

Location

Eatontown, NJ

🇺🇸
🏢

Address

246 Industrial Way W, , Eatontown, NJ, United States

Moderate Risk

FDA Import Risk Assessment

40.9
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

4
Total Refusals
2
Unique Violations
3/22/2023
Latest Refusal
9/14/2011
Earliest Refusal

Score Breakdown

Violation Severity
67.5×40%
Refusal Volume
25.9×30%
Recency
29.0×20%
Frequency
3.5×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

1793×

AGR RX

The article appears to be a prescription drug manufactured in the U.S. and offered for import by other than the manufacturer and reimportation does not appear to have been authorized by the Secretary for use in a medical emergency.

751×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

Refusal History

DateProductViolationsDivision
3/22/2023
66SDO28NITROGLYCERIN (TAB) (VASODILATOR)
179AGR RX
Division of West Coast Imports (DWCI)
3/22/2023
60QDP82FLUMAZENIL (ANESTHETIC)
179AGR RX
Division of West Coast Imports (DWCI)
11/4/2011
56BCZ03AMOXICILLIN TRIHYDRATE (PENICILLIN, SYNTHETICALLY PRODUCED)
75UNAPPROVED
Cincinnati District Office (CIN-DO)
9/14/2011
64LCY06BETAMETHASONE DIPROPIONATE (GLUCOCORTICOID)
179AGR RX
Division of Southeast Imports (DSEI)

Frequently Asked Questions

What is Hikma Pharmaceuticals USA, Inc.'s FDA import refusal history?

Hikma Pharmaceuticals USA, Inc. (FEI: 2250102) has 4 FDA import refusal record(s) in our database, spanning from 9/14/2011 to 3/22/2023.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Hikma Pharmaceuticals USA, Inc.'s FEI number is 2250102.

What types of violations has Hikma Pharmaceuticals USA, Inc. received?

Hikma Pharmaceuticals USA, Inc. has been cited for 2 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Hikma Pharmaceuticals USA, Inc. come from?

All FDA import refusal data for Hikma Pharmaceuticals USA, Inc. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.